<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Boel Hawkins | Activity</title>
	<link>https://www.catswannabecats.com/members/cherrybutter31/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/cherrybutter31/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Boel Hawkins.</description>
	<lastBuildDate>Thu, 25 Jun 2026 06:52:40 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">4c2f17be3e2c27c34d4a63820de481e2</guid>
				<title>Boel Hawkins posted an update: 32; 95% CI, 1.12 to 1.55; P less then 0.001). The [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/25301/</link>
				<pubDate>Sun, 08 Jun 2025 19:43:27 -0400</pubDate>

									<content:encoded><![CDATA[<p>32; 95% CI, 1.12 to 1.55; P less then 0.001). The Kaplan-Meier estimates of mortality by 14 days were 7.1% with remdesivir and 11.9% with placebo (hazard ratio for death, 0.70; 95% CI, 0.47 to 1.04). Serious adverse events were reported for 114 of the 541 patients in the remdesivir group who underwent randomization (21.1%) and 141 of the 522&hellip;<span class="activity-read-more" id="activity-read-more-25301"><a href="https://www.catswannabecats.com/activity/p/25301/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">895baf63ff06376fa21390cb6e9607d2</guid>
				<title>Boel Hawkins posted an update: chain AHLs enhances current knowledge regarding the variety [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23004/</link>
				<pubDate>Sat, 07 Jun 2025 16:59:04 -0400</pubDate>

									<content:encoded><![CDATA[<p>chain AHLs enhances current knowledge regarding the variety of AHLs produced by this enzyme. These structural data are expected to serve as a molecular rationale for AHL synthesis by AhyI.Farnesoid X receptor (FXR) agonists can reverse dysregulated bile acid metabolism, and thus, they are potential therapeutics to prevent and treat nonalcoholic&hellip;<span class="activity-read-more" id="activity-read-more-23004"><a href="https://www.catswannabecats.com/activity/p/23004/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">70f86b8dfda979614116859ff729ca5f</guid>
				<title>Boel Hawkins posted an update: These results, together with an excellent cytocompatibility [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/20033/</link>
				<pubDate>Thu, 05 Jun 2025 11:07:48 -0400</pubDate>

									<content:encoded><![CDATA[<p>These results, together with an excellent cytocompatibility towards primary gingival fibroblasts, encourage the use of ELRs as multivalent platforms for AMPs and open up a wide range of possibilities in the biofabrication of advanced coatings combining the antibiofilm potential of AMPs and the outstanding tunability and biomechanical properties of&hellip;<span class="activity-read-more" id="activity-read-more-20033"><a href="https://www.catswannabecats.com/activity/p/20033/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9151f92630c90694ef0c89faffcfd139</guid>
				<title>Boel Hawkins posted an update: Inhibition of HDAC4 also improved cardiac function in HF [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/18908/</link>
				<pubDate>Wed, 04 Jun 2025 11:30:33 -0400</pubDate>

									<content:encoded><![CDATA[<p>Inhibition of HDAC4 also improved cardiac function in HF mice. Moreover, knockdown of GLUT1 impaired the systolic and diastolic function of isolated cardiomyocytes. In conclusion,&nbsp;exercise improves cardiac function and glucose metabolism in HF mice through inhibiting HDAC4 and upregulating GLUT1 expression.Metabolic engineering is usually focused&hellip;<span class="activity-read-more" id="activity-read-more-18908"><a href="https://www.catswannabecats.com/activity/p/18908/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1ce3f1ec3dd77e58dd6b8d8b12143dba</guid>
				<title>Boel Hawkins posted an update: This resulted in a 165% (95% CI, 79% to 294%) increase in [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/5125/</link>
				<pubDate>Sat, 31 May 2025 14:29:51 -0400</pubDate>

									<content:encoded><![CDATA[<p>This resulted in a 165% (95% CI, 79% to 294%) increase in afferent compliance and a 13.1-mm Hg (95% CI, 10.0 to 16.3) decrease in Pglom. In multiple linear regression analysis, diabetes (coefficient, 10.1; 95% CI, 5.1 to 15.1), BMI (0.99 per kg/m2; 95% CI, 0.38 to 1.59), and renal perfusion pressure (0.42 per mm Hg; 95% CI, 0.25 to 0.59) were&hellip;<span class="activity-read-more" id="activity-read-more-5125"><a href="https://www.catswannabecats.com/activity/p/5125/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4bd1fcb88a812fd20929713cd36ea025</guid>
				<title>Boel Hawkins became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/4979/</link>
				<pubDate>Sat, 31 May 2025 14:21:16 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>